Predictions
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€13.06
26.03.24
26.03.24
€20.00
21.03.25
21.03.25
-18.95%
01.09.24
01.09.24
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€39.49
31.08.23
31.08.23
€55.34
31.08.24
31.08.24
46.16%
01.09.24
01.09.24
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€168.60
08.08.23
08.08.23
€228.30
08.08.24
08.08.24
46.56%
09.08.24
09.08.24
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€168.60
04.08.23
04.08.23
€244.57
04.08.24
04.08.24
44.72%
05.08.24
05.08.24
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€168.00
04.08.23
04.08.23
€217.73
04.08.24
04.08.24
45.24%
05.08.24
05.08.24
United Therapeutics
Start price
Target price
Perf. (%)
€212.40
03.08.23
03.08.23
€290.24
03.08.24
03.08.24
32.72%
04.08.24
04.08.24
United Therapeutics
Start price
Target price
Perf. (%)
€219.60
03.08.23
03.08.23
€274.20
03.08.24
03.08.24
28.37%
04.08.24
04.08.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€94.60
02.08.23
02.08.23
€137.10
02.08.24
02.08.24
47.73%
03.08.24
03.08.24
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€236.00
25.07.23
25.07.23
€247.47
25.07.24
25.07.24
50.85%
26.07.24
26.07.24
Catalent Inc.
Start price
Target price
Perf. (%)
€33.15
19.05.23
19.05.23
€40.00
19.05.24
19.05.24
54.24%
20.05.24
20.05.24
Could be worthwhile Investment >10% per year
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€89.90
30.03.23
30.03.23
€120.95
30.03.24
30.03.24
47.22%
01.04.24
01.04.24
Invitae Corp
Start price
Target price
Perf. (%)
€1.30
11.03.23
11.03.23
€0.40
11.03.24
11.03.24
-93.65%
12.03.24
12.03.24
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Nektar Therapeutics
Start price
Target price
Perf. (%)
€1.32
28.02.23
28.02.23
€1.88
28.02.24
28.02.24
-50.72%
29.02.24
29.02.24
Fibrogen Inc.
Start price
Target price
Perf. (%)
€0.88
25.01.24
25.01.24
€1.30
25.01.25
25.01.25
143.18%
19.02.24
19.02.24
Could be very worthwhile Investment >20% year
Global Blood Therapeutics Inc
Start price
Target price
Perf. (%)
€33.09
30.10.21
30.10.21
€45.00
31.12.23
31.12.23
94.65%
05.08.22
05.08.22
Could be very worthwhile Investment >20% year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€152.65
16.11.21
16.11.21
€200.00
31.01.25
31.01.25
36.59%
03.08.22
03.08.22
Could be worthwhile Investment >10% per year
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€9.23
09.11.21
09.11.21
€7.00
31.12.23
31.12.23
-56.18%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Invitae Corp
Start price
Target price
Perf. (%)
€20.09
09.11.21
09.11.21
€17.00
31.12.23
31.12.23
-23.92%
01.12.21
01.12.21
Could be very worthwhile Investment >20% year
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€91.00
24.09.20
24.09.20
€145.00
04.11.21
04.11.21
114.29%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€64.30
31.08.20
31.08.20
€66.00
04.11.21
04.11.21
55.52%
05.11.21
05.11.21
Ironwood Pharmaceuticals
Start price
Target price
Perf. (%)
€8.95
25.08.20
25.08.20
€10.00
04.11.21
04.11.21
15.08%
05.11.21
05.11.21
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€121.45
21.08.20
21.08.20
€130.00
04.11.21
04.11.21
19.06%
05.11.21
05.11.21